NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION

Clinical trials for NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION explained in plain language.

Never miss a new study

Get alerted when new NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION trials appear

Sign up with your email to follow new studies for NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Two-Drug eye treatment could cut injection visits in half

Disease control Completed

This study tested whether adding Ozurdex to standard Avastin eye injections could help patients with retinal vein blockage need fewer injections over time. Researchers enrolled 68 adults with this specific eye condition to compare treatment approaches. The main goal was to see if…

Matched conditions: NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION

Phase: PHASE2, PHASE3 • Sponsor: Texas Retina Associates • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION

Get alerted when new NON-ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION trials appear

Two-Drug eye treatment could cut injection visits in half